Hungerford Brian's Form 4 filing
Kiromic Biopharma, Inc. (KRBP) · filed Aug 21, 2024
- Accession no.
- 0001437749-24-027492
- Filed
- Aug 21, 2024
- Trade date
- Aug 19-20, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $8.81K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hungerford BrianCIK 0001981345 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | Common Stock | PPurchaseAcquired | +258 | $2.25 | +$580.5 | 61,191 | Direct | |
| Aug 20, 2024 | Common Stock | PPurchaseAcquired | +3,742 | $2.20 | +$8,232.4 | 64,933 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.